BSE Live
Oct 29, 16:01Prev. Close
843.55
Open Price
834.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 29, 15:57Prev. Close
843.00
Open Price
843.00
Bid Price (Qty.)
831.90 (75)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Aarti Pharmalabs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 336.34 | 274.52 | 233.36 | 133.73 | 0.00 | |
| Net CashFlow From Operating Activities | 340.01 | 183.69 | 228.69 | -64.84 | 0.00 | |
| Net Cash Used In Investing Activities | -419.80 | -184.40 | -115.55 | -133.54 | 0.00 | |
| Net Cash Used From Financing Activities | 78.63 | 4.40 | -156.53 | 254.63 | 0.00 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -1.16 | 3.70 | -43.39 | 56.25 | 0.00 | |
| Cash And Cash Equivalents Begin of Year | 4.00 | 0.30 | 56.50 | 0.25 | 0.25 | |
| Cash And Cash Equivalents End Of Year | 2.84 | 4.00 | 13.11 | 56.50 | 0.25 |
22.09.2025
19.09.2025
15.05.2025
AARTIPHARM Standalone March 2025 Net Sales at Rs 529.62 crore, up 27.68% Y-o-Y
12.05.2025
AARTIPHARM Consolidated March 2025 Net Sales at Rs 563.78 crore, up 11.47% Y-o-Y
15.05.2025
AARTIPHARM Standalone March 2025 Net Sales at Rs 529.62 crore, up 27.68% Y-o-Y
12.05.2025
AARTIPHARM Consolidated March 2025 Net Sales at Rs 563.78 crore, up 11.47% Y-o-Y
06.02.2025
AARTIPHARM Consolidated December 2024 Net Sales at Rs 537.78 crore, up 19.86% Y-o-Y
06.02.2025
AARTIPHARM Standalone December 2024 Net Sales at Rs 470.95 crore, up 26.25% Y-o-Y